You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Medical Care

Global Active Pharmaceutical Ingredient Market Analysis 2016-2020 and Forecast 2021-2026

Snapshot

Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it. API also refers to the active or central ingredient in the product which causes the direct effect on the disease diagnosis, prevention, treatment or cure. While API is the active component of a drug, excipients are the inactive or inert substances present in a drug.
The global Active Pharmaceutical Ingredient market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Active Pharmaceutical Ingredient by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Synthetic API
Biotech API
Others

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Teva
Novartis
Pfizer
Johnson & Johnson
Mylan
North China Pharmaceutical Group
Dr. Reddy’s Laboratories
Roche
Aurobindo pharma
Sun Pharmaceutical Industries
Boehringer Ingelheim GmbH
Bayer
BASF
DSM
Zhejiang Medicine
Biocon
Johnson Matthey
Hisun Pharmacy
Cambrex
Shandong Xinhua Pharmaceutical
Lonza group
Huahai Pharmaceutical
Haerbin Pharmaceutical Group
Cipla
Tian Yao
Lupin
North East Pharmaceutical
Albemarle
Shandong Lukang Pharmaceutical
Jiangsu Hengrui Medicine
Bachem

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
Oncology Drugs
Anti-diabetic Drugs
Cardiovascular Drugs
Central Nervous System Drugs (CNS Drugs)
Musculoskeletal Drugs
Other Drugs

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Table of Contents
1 Industry Overview
1.1 Active Pharmaceutical Ingredient Industry
Figure Active Pharmaceutical Ingredient Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Active Pharmaceutical Ingredient
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Active Pharmaceutical Ingredient
1.2.2 Downstream
Table Application Segment of Active Pharmaceutical Ingredient
Table Global Active Pharmaceutical Ingredient Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Active Pharmaceutical Ingredient Market by Type
3.1 By Type
3.1.1 Synthetic API
Table Major Company List of Synthetic API
3.1.2 Biotech API
Table Major Company List of Biotech API
3.1.3 Others
Table Major Company List of Others
3.2 Market Size
Table Global Active Pharmaceutical Ingredient Market 2016-2020, by Type, in USD Million
Figure Global Active Pharmaceutical Ingredient Market Growth 2016-2020, by Type, in USD Million
Table Global Active Pharmaceutical Ingredient Market 2016-2020, by Type, in Volume
Figure Global Active Pharmaceutical Ingredient Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Active Pharmaceutical Ingredient Market Forecast 2021-2026, by Type, in USD Million
Table Global Active Pharmaceutical Ingredient Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 Teva (Company Profile, Sales Data etc.)
4.1.1 Teva Profile
Table Teva Overview List
4.1.2 Teva Products & Services
4.1.3 Teva Business Operation Conditions
Table Business Operation of Teva (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Novartis (Company Profile, Sales Data etc.)
4.2.1 Novartis Profile
Table Novartis Overview List
4.2.2 Novartis Products & Services
4.2.3 Novartis Business Operation Conditions
Table Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Pfizer (Company Profile, Sales Data etc.)
4.3.1 Pfizer Profile
Table Pfizer Overview List
4.3.2 Pfizer Products & Services
4.3.3 Pfizer Business Operation Conditions
Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Johnson & Johnson (Company Profile, Sales Data etc.)
4.4.1 Johnson & Johnson Profile
Table Johnson & Johnson Overview List
4.4.2 Johnson & Johnson Products & Services
4.4.3 Johnson & Johnson Business Operation Conditions
Table Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Mylan (Company Profile, Sales Data etc.)
4.5.1 Mylan Profile
Table Mylan Overview List
4.5.2 Mylan Products & Services
4.5.3 Mylan Business Operation Conditions
Table Business Operation of Mylan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 North China Pharmaceutical Group (Company Profile, Sales Data etc.)
4.6.1 North China Pharmaceutical Group Profile
Table North China Pharmaceutical Group Overview List
4.6.2 North China Pharmaceutical Group Products & Services
4.6.3 North China Pharmaceutical Group Business Operation Conditions
Table Business Operation of North China Pharmaceutical Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Dr. Reddy’s Laboratories (Company Profile, Sales Data etc.)
4.7.1 Dr. Reddy’s Laboratories Profile
Table Dr. Reddy’s Laboratories Overview List
4.7.2 Dr. Reddy’s Laboratories Products & Services
4.7.3 Dr. Reddy’s Laboratories Business Operation Conditions
Table Business Operation of Dr. Reddy’s Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Roche (Company Profile, Sales Data etc.)
4.8.1 Roche Profile
Table Roche Overview List
4.8.2 Roche Products & Services
4.8.3 Roche Business Operation Conditions
Table Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Aurobindo pharma (Company Profile, Sales Data etc.)
4.9.1 Aurobindo pharma Profile
Table Aurobindo pharma Overview List
4.9.2 Aurobindo pharma Products & Services
4.9.3 Aurobindo pharma Business Operation Conditions
Table Business Operation of Aurobindo pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Sun Pharmaceutical Industries (Company Profile, Sales Data etc.)
4.10.1 Sun Pharmaceutical Industries Profile
Table Sun Pharmaceutical Industries Overview List
4.10.2 Sun Pharmaceutical Industries Products & Services
4.10.3 Sun Pharmaceutical Industries Business Operation Conditions
Table Business Operation of Sun Pharmaceutical Industries (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 Boehringer Ingelheim GmbH (Company Profile, Sales Data etc.)
4.11.1 Boehringer Ingelheim GmbH Profile
Table Boehringer Ingelheim GmbH Overview List
4.11.2 Boehringer Ingelheim GmbH Products & Services
4.11.3 Boehringer Ingelheim GmbH Business Operation Conditions
Table Business Operation of Boehringer Ingelheim GmbH (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 Bayer (Company Profile, Sales Data etc.)
4.12.1 Bayer Profile
Table Bayer Overview List
4.12.2 Bayer Products & Services
4.12.3 Bayer Business Operation Conditions
Table Business Operation of Bayer (Sales Revenue, Cost, Gross Margin)
4.13 BASF (Company Profile, Sales Data etc.)
4.13.1 BASF Profile
Table BASF Overview List
4.13.2 BASF Products & Services
4.13.3 BASF Business Operation Conditions
Table Business Operation of BASF (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.14 DSM (Company Profile, Sales Data etc.)
4.14.1 DSM Profile
Table DSM Overview List
4.14.2 DSM Products & Services
4.14.3 DSM Business Operation Conditions
Table Business Operation of DSM (Sales Revenue, Cost, Gross Margin)
4.15 Zhejiang Medicine (Company Profile, Sales Data etc.)
4.15.1 Zhejiang Medicine Profile
Table Zhejiang Medicine Overview List
4.15.2 Zhejiang Medicine Products & Services
4.15.3 Zhejiang Medicine Business Operation Conditions
Table Business Operation of Zhejiang Medicine (Sales Revenue, Cost, Gross Margin)
4.16 Biocon (Company Profile, Sales Data etc.)
4.16.1 Biocon Profile
Table Biocon Overview List
4.16.2 Biocon Products & Services
4.16.3 Biocon Business Operation Conditions
Table Business Operation of Biocon (Sales Revenue, Cost, Gross Margin)
4.17 Johnson Matthey (Company Profile, Sales Data etc.)
4.17.1 Johnson Matthey Profile
Table Johnson Matthey Overview List
4.17.2 Johnson Matthey Products & Services
4.17.3 Johnson Matthey Business Operation Conditions
Table Business Operation of Johnson Matthey (Sales Revenue, Cost, Gross Margin)
4.18 Hisun Pharmacy (Company Profile, Sales Data etc.)
4.18.1 Hisun Pharmacy Profile
Table Hisun Pharmacy Overview List
4.18.2 Hisun Pharmacy Products & Services
4.18.3 Hisun Pharmacy Business Operation Conditions
Table Business Operation of Hisun Pharmacy (Sales Revenue, Cost, Gross Margin)
4.19 Cambrex (Company Profile, Sales Data etc.)
4.19.1 Cambrex Profile
Table Cambrex Overview List
4.19.2 Cambrex Products & Services
4.19.3 Cambrex Business Operation Conditions
Table Business Operation of Cambrex (Sales Revenue, Cost, Gross Margin)
4.20 Shandong Xinhua Pharmaceutical (Company Profile, Sales Data etc.)
4.20.1 Shandong Xinhua Pharmaceutical Profile
Table Shandong Xinhua Pharmaceutical Overview List
4.20.2 Shandong Xinhua Pharmaceutical Products & Services
4.20.3 Shandong Xinhua Pharmaceutical Business Operation Conditions
Table Business Operation of Shandong Xinhua Pharmaceutical (Sales Revenue, Cost, Gross Margin)
4.21 Lonza group (Company Profile, Sales Data etc.)
4.21.1 Lonza group Profile
Table Lonza group Overview List
4.21.2 Lonza group Products & Services
4.21.3 Lonza group Business Operation Conditions
Table Business Operation of Lonza group (Sales Revenue, Cost, Gross Margin)
4.22 Huahai Pharmaceutical (Company Profile, Sales Data etc.)
4.22.1 Huahai Pharmaceutical Profile
Table Huahai Pharmaceutical Overview List
4.22.2 Huahai Pharmaceutical Products & Services
4.22.3 Huahai Pharmaceutical Business Operation Conditions
Table Business Operation of Huahai Pharmaceutical (Sales Revenue, Cost, Gross Margin)
4.23 Haerbin Pharmaceutical Group (Company Profile, Sales Data etc.)
4.23.1 Haerbin Pharmaceutical Group Profile
Table Haerbin Pharmaceutical Group Overview List
4.23.2 Haerbin Pharmaceutical Group Products & Services
4.23.3 Haerbin Pharmaceutical Group Business Operation Conditions
Table Business Operation of Haerbin Pharmaceutical Group (Sales Revenue, Cost, Gross Margin)
4.24 Cipla (Company Profile, Sales Data etc.)
4.24.1 Cipla Profile
Table Cipla Overview List
4.24.2 Cipla Products & Services
4.24.3 Cipla Business Operation Conditions
Table Business Operation of Cipla (Sales Revenue, Cost, Gross Margin)
4.25 Tian Yao (Company Profile, Sales Data etc.)
4.25.1 Tian Yao Profile
Table Tian Yao Overview List
4.25.2 Tian Yao Products & Services
4.25.3 Tian Yao Business Operation Conditions
Table Business Operation of Tian Yao (Sales Revenue, Cost, Gross Margin)
4.26 Lupin (Company Profile, Sales Data etc.)
4.26.1 Lupin Profile
Table Lupin Overview List
4.26.2 Lupin Products & Services
4.26.3 Lupin Business Operation Conditions
Table Business Operation of Lupin (Sales Revenue, Cost, Gross Margin)
4.27 North East Pharmaceutical (Company Profile, Sales Data etc.)
4.27.1 North East Pharmaceutical Profile
Table North East Pharmaceutical Overview List
4.27.2 North East Pharmaceutical Products & Services
4.27.3 North East Pharmaceutical Business Operation Conditions
Table Business Operation of North East Pharmaceutical (Sales Revenue, Cost, Gross Margin)
4.28 Albemarle (Company Profile, Sales Data etc.)
4.28.1 Albemarle Profile
Table Albemarle Overview List
4.28.2 Albemarle Products & Services
4.28.3 Albemarle Business Operation Conditions
Table Business Operation of Albemarle (Sales Revenue, Cost, Gross Margin)
4.29 Shandong Lukang Pharmaceutical (Company Profile, Sales Data etc.)
4.29.1 Shandong Lukang Pharmaceutical Profile
Table Shandong Lukang Pharmaceutical Overview List
4.29.2 Shandong Lukang Pharmaceutical Products & Services
4.29.3 Shandong Lukang Pharmaceutical Business Operation Conditions
Table Business Operation of Shandong Lukang Pharmaceutical (Sales Revenue, Cost, Gross Margin)
4.30 Jiangsu Hengrui Medicine (Company Profile, Sales Data etc.)
4.30.1 Jiangsu Hengrui Medicine Profile
Table Jiangsu Hengrui Medicine Overview List
4.30.2 Jiangsu Hengrui Medicine Products & Services
4.30.3 Jiangsu Hengrui Medicine Business Operation Conditions
Table Business Operation of Jiangsu Hengrui Medicine (Sales Revenue, Cost, Gross Margin)
4.31 Bachem (Company Profile, Sales Data etc.)
5 Market Competition
5.1 Company Competition
Table Global Active Pharmaceutical Ingredient Sales Revenue 2016-2020, by Company, in USD Million
Table Global Active Pharmaceutical Ingredient Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Active Pharmaceutical Ingredient Sales Revenue Share in 2020, by Company, in USD Million
Table Global Active Pharmaceutical Ingredient Sales Volume 2016-2020, by Company, in Volume
Table Global Active Pharmaceutical Ingredient Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Active Pharmaceutical Ingredient Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Active Pharmaceutical Ingredient Market Concentration, in 2020
Figure Europe Active Pharmaceutical Ingredient Market Market Concentration, in 2020
Figure Asia-Pacific Active Pharmaceutical Ingredient MMarket Concentration, in 2020
Figure South America Active Pharmaceutical Ingredient Market Concentration, in 2020
Figure Middle East & Africa Active Pharmaceutical Ingredient Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Non-steroidal Anti-inflammatory Drugs (NSAIDs)
Figure Active Pharmaceutical Ingredient Demand in Non-steroidal Anti-inflammatory Drugs (NSAIDs), 2016-2020, in USD Million
Figure Active Pharmaceutical Ingredient Demand in Non-steroidal Anti-inflammatory Drugs (NSAIDs), 2016-2020, in Volume
6.1.2 Demand in Oncology Drugs
Figure Active Pharmaceutical Ingredient Demand in Oncology Drugs, 2016-2020, in USD Million
Figure Active Pharmaceutical Ingredient Demand in Oncology Drugs, 2016-2020, in Volume
6.1.3 Demand in Anti-diabetic Drugs
Figure Active Pharmaceutical Ingredient Demand in Anti-diabetic Drugs, 2016-2020, in USD Million
Figure Active Pharmaceutical Ingredient Demand in Anti-diabetic Drugs, 2016-2020, in Volume
6.1.4 Demand in Cardiovascular Drugs
Figure Active Pharmaceutical Ingredient Demand in Cardiovascular Drugs, 2016-2020, in USD Million
Figure Active Pharmaceutical Ingredient Demand in Cardiovascular Drugs, 2016-2020, in Volume
6.1.5 Demand in Central Nervous System Drugs (CNS Drugs)
Figure Active Pharmaceutical Ingredient Demand in Central Nervous System Drugs (CNS Drugs), 2016-2020, in USD Million
Figure Active Pharmaceutical Ingredient Demand in Central Nervous System Drugs (CNS Drugs), 2016-2020, in Volume
6.1.6 Demand in Musculoskeletal Drugs
Figure Active Pharmaceutical Ingredient Demand in Musculoskeletal Drugs, 2016-2020, in USD Million
Figure Active Pharmaceutical Ingredient Demand in Musculoskeletal Drugs, 2016-2020, in Volume
6.1.7 Demand in Other Drugs
Figure Active Pharmaceutical Ingredient Demand in Other Drugs, 2016-2020, in USD Million
Figure Active Pharmaceutical Ingredient Demand in Other Drugs, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Active Pharmaceutical Ingredient Demand Forecast 2021-2026, by Application, in USD Million
Figure Active Pharmaceutical Ingredient Market Growth 2021-2026, by Application, in USD Million
Figure Active Pharmaceutical Ingredient Market Share in 2026, by Application, in USD Million
Table Active Pharmaceutical Ingredient Demand Forecast 2021-2026, by Application, in Volume
Table Active Pharmaceutical Ingredient Market Growth 2021-2026, by Application, in Volume
Table Active Pharmaceutical Ingredient Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Active Pharmaceutical Ingredient Production 2016-2020, by Region, in USD Million
Table Active Pharmaceutical Ingredient Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Active Pharmaceutical Ingredient Market 2016-2020, by Region, in USD Million
Table Global Active Pharmaceutical Ingredient Market Share 2016-2020, by Region, in USD Million
Table Global Active Pharmaceutical Ingredient Market 2016-2020, by Region, in Volume
Table Global Active Pharmaceutical Ingredient Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Active Pharmaceutical Ingredient Market Size and Growth 2016-2020, in USD Million
Figure North America Active Pharmaceutical Ingredient Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Active Pharmaceutical Ingredient Market Size 2016-2020, by Country, in USD Million
Table North America Active Pharmaceutical Ingredient Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Active Pharmaceutical Ingredient Market Size and Growth 2016-2020, in USD Million
Figure Europe Active Pharmaceutical Ingredient Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Active Pharmaceutical Ingredient Market Size 2016-2020, by Country, in USD Million
Table Europe Active Pharmaceutical Ingredient Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Active Pharmaceutical Ingredient Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Active Pharmaceutical Ingredient Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Active Pharmaceutical Ingredient Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Active Pharmaceutical Ingredient Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Active Pharmaceutical Ingredient Market Size and Growth 2016-2020, in USD Million
Figure South America Active Pharmaceutical Ingredient Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Active Pharmaceutical Ingredient Market Size 2016-2020, by Country, in USD Million
Table South America Active Pharmaceutical Ingredient Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Active Pharmaceutical Ingredient Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Active Pharmaceutical Ingredient Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Active Pharmaceutical Ingredient Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Active Pharmaceutical Ingredient Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Active Pharmaceutical Ingredient Market Forecast 2021-2026, by Region, in USD Million
Table Active Pharmaceutical Ingredient Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
  • FORMAT: PDF
  • PUBLISHED DATE: Feb, 2021
  • NO OF PAGES: 44236